SQZ Biotechnologies (SQZ) Announces Leadership Transition

Go back to SQZ Biotechnologies (SQZ) Announces Leadership Transition

SQZ Biotechnologies Announces Leadership Transition

September 6, 2022 4:30 PM EDT

Chief Scientific Officer, Howard Bernstein, M.D., Ph.D., to Become Member of the Companys Board of Directors, Effective October 31, 2022

CSO Responsibilities to be Shared Among Ipsita Roymoulik, Ph.D., Scott Loughhead, Ph.D., and Maisam Dadgar as Senior Leaders of Chemistry, Manufacturing and Controls; Translational Research; and Engineering

WATERTOWN, Mass.--(BUSINESS... More